Finance

Beta
Lists
OM:NASDAQ
Outset Medical Inc
$4.58
-0.22%
(-0.010) 1D
$4.53
-1.03% (-0.047)
After hours
Closed: Jun 26, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OM...
Open
$4.58
High
$5.11
Low
$4.49
Mkt. cap
84.90M
Avg. vol.
200.26K
Volume
2.21M
52-wk high
$21.36
52-wk low
$3.00
EPS
-$4.15
Beta
1.95
Shares outstanding
18.54M
No. of employees
310
Open
$4.58
High
$5.11
Low
$4.49
Mkt. cap
84.90M
Avg. vol.
200.26K
Volume
2.21M
52-wk high
$21.36
52-wk low
$3.00
EPS
-$4.15
Beta
1.95
Shares outstanding
18.54M
No. of employees
310
News stories
From sources across the web
About Outset Medical Inc
CEO-
Employees310
Founded2003
HeadquartersSan Jose, California, United States
SectorMedical device
Websiteoutsetmedical.com
Analyst ratings
Based on 3 analysts giving stock ratings to OM in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for OM in the last 3 months.
Highest
Current $4.58
$10.00 (+118.34%)
Average
$7.67 (+67.47%)
Lowest
$6.00 (+31.00%)
Analyst
Recommendation
Action
Price target
Projected
Date
Josh Jennings
TD Cowen
Buy
Reiterated
$10.00
+118.3%
05/08/2026
Rick Wise
Stifel Nicolaus
Buy
Reiterated
$6.00
+31%
05/08/2026
Shagun Singh Chadha
RBC Capital
Hold
Reiterated
$7.00
+52.8%
05/08/2026
William Katz
TD Cowen
Buy
Reiterated
$12.00
+162%
04/07/2026
Marie Thibault
BTIG
Buy
Maintained
$15.00
+227.5%
02/18/2026
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.83 / -$0.79
-5.06%miss
Revenue / Est. (USD)
27.86M / 28.90M
-3.59%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
31.42M
29.43M
28.87M
27.86M
Cost of goods sold
19.55M
17.84M
16.64M
15.77M
Cost of revenue
19.55M
17.84M
16.64M
15.77M
Research and development expenses
5.29M
5.38M
5.06M
5.62M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
23.44M
22.03M
24.80M
23.40M
Operating expense
28.73M
27.40M
29.86M
29.01M
Total operating expenses
48.28M
45.24M
46.50M
44.78M
Operating income
-16.86M
-15.81M
-17.63M
-16.92M
Other non operating income
-
-
-
-
EBT including unusual items
-18.44M
-17.43M
-19.40M
-18.76M
EBT excluding unusual items
-18.44M
-17.43M
-19.40M
-18.76M
Income tax expense
104.00K
404.00K
95.00K
217.00K
Effective tax rate
-0.56%
-2.32%
-0.49%
-1.16%
Other operating expenses
-
-
-
-
Net income
-18.54M
-17.84M
-19.49M
-18.98M
Net profit margin
-59.01%
-60.61%
-67.50%
-68.11%
Earnings per share
-0.84
-0.69
-0.84
-0.83
Interest and investment income
1.90M
1.86M
1.67M
1.53M
Interest expense
-3.48M
-3.48M
-3.44M
-3.37M
Net interest expenses
-1.57M
-1.62M
-1.77M
-1.84M
Depreciation and amortization charges
-
-
-
-
EBITDA
-15.71M
-14.80M
-16.75M
-16.12M
Gain or loss from assets sale
2.00K
3.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of OM
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer